Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P A Haslett

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
The Journal of Infectious Diseases|June 1, 1996
A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137)F T Valentine, S Kundu, P A Haslett, et al.
AIDS Research and Human Retroviruses|September 10, 1999
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patientsP A Haslett, J D Klausner, S Makonkawkeyoon, et al.
Journal of Virology|January 7, 2000
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cellsH M Spiegel, G S Ogg, E DeFalcon, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
The Journal of Infectious Diseases|June 1, 1996
A randomized, placebo-controlled study of the immunogenicity of human immunodeficiency virus (HIV) rgp160 vaccine in HIV-infected subjects with > or = 400/mm3 CD4 T lymphocytes (AIDS Clinical Trials Group Protocol 137)F T Valentine, S Kundu, P A Haslett, et al.
AIDS Research and Human Retroviruses|September 10, 1999
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patientsP A Haslett, J D Klausner, S Makonkawkeyoon, et al.
Journal of Virology|January 7, 2000
Human immunodeficiency virus type 1- and cytomegalovirus-specific cytotoxic T lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cellsH M Spiegel, G S Ogg, E DeFalcon, et al.
Pageof 2